AEXERNA THERAPEUTICS
Summary
aexeRNA Therapeutics is developing mRNA therapeutics utilizing its proprietary next generation programmable and highly potent Lipid Nanoparticle nucleic acid delivery system.
Deals Overview
Total Deals1
Valued Deals1
Total Value£812M
Avg. Deal Size£812M
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
